Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients [PDF]
Biomedicines, 2023 Bladder inflammation and tissue hypoxia were considered important pathognomonic bladder features in detrusor underactivity (DU) and detrusor overactivity (DO) patients.
Yuan-Hong Jiang +3 more
doaj +4 more sources
Detrusor-Overactivity-Related Voiding in Women Mimics Bladder Outflow Obstruction and Conceals Underactivity [PDF]
Urology Research and Practice, 2023 Objective: Urodynamics of the storage phase showing detrusor overactivity is com- mon in neurogenic bladder patients. Terminal detrusor overactivity, which is defined by involuntary detrusor contraction that cannot be inhibited, causes urinary incon ...
Takeya Kitta +9 more
doaj +2 more sources
Urodynamic characteristics of different types of detrusor overactivity in patients with benign prostatic obstruction [PDF]
Frontiers in UrologyBackgroundThis study aimed to investigate whether the presence or the absence of detrusor overactivity (DO) in patients with urodynamic-confirmed benign prostatic obstruction (BPO) leads to alterations in urodynamic parameters.MethodsThis study is a ...
Xiao Zeng +4 more
doaj +2 more sources
Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough‐associated detrusor overactivity [PDF]
IJU Case ReportsIntroduction We report a case of refractory overactive bladder with cough‐associated detrusor overactivity treated by onabotulinumtoxin A. Case presentation A 79‐year‐old woman who underwent mid‐urethral sling surgery 8 years ago complained mainly of ...
Chie Nakai +6 more
doaj +2 more sources
Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis [PDF]
International Neurourology Journal, 2017 Purpose OnabotulinumtoxinA is used widely for the treatment of neurogenic detrusor overactivity. We conducted a systematic review and meta-analysis to assess its efficacy and safety for neurogenic detrusor overactivity treatment.
Hejia Yuan +5 more
doaj +2 more sources
Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements [PDF]
Life, 2023 Introduction: It has been hypothesized that the urinary microbiome might play an important role in OAB. Studies have been conducted on the association between OAB symptoms and the microbiome, although a possible causality still has to be determined ...
Aida Javan Balegh Marand +6 more
doaj +2 more sources
Scientific Reports, 2021 The pathophysiologies of metabolic syndrome (MS) and overactive bladder (OAB) might overlap. Using fructose-fed rats (FFRs) as a rodent model of MS we investigated the effects of tadalafil (a phosphodiesterase type 5 inhibitor) on the dysregulated ...
Wei-Chia Lee +5 more
doaj +1 more source
Taiwanese Journal of Obstetrics & Gynecology, 2020 Objectives: Some symptoms of overactive bladder overlap with those of interstitial cystitis. This study was conducted to compare the urodynamic results and quality of life of patients with the two conditions.
Chin-Chieh Hsu +4 more
doaj +1 more source
Journal of Rehabilitation Medicine, 2022 Objective: To investigate the effects of concomitant injections of botulinum toxin-A (BoNT-A) into the detrusor and external urethral sphincter muscles in suprasacral spinal cord injured patients with detrusor overactivity and detrusor sphincter ...
Yu-Hui Huang, Sung-Lang Chen
doaj +1 more source
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]
Investigative and Clinical Urology, 2020 After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj +1 more source